IL-1 family nomenclature
Charles A. Dinarello(University of Colorado Health), Chiristopher Gabel(Amgen (United States)), Philip Bufler(Ludwig-Maximilians-Universität München), William P. Arend(University of Colorado Denver), Marc Y. Donath(University of Basel), Hal M. Hoffman(University of California San Diego), Michael U. Martin(Justus-Liebig-Universität Gießen), Mihai G. Netea(Radboud University Nijmegen), H Muehl(Goethe University Frankfurt), Leo A. B. Joosten(Radboud University Nijmegen), Marcel F. Nold(Hudson Institute of Medical Research), Cecília Garlanda(Humanitas University), Dirk E. Smith(Amgen (United States)), Hal Blumberg(Novo Nordisk (United States)), Alberto Mantovani(Humanitas University), Eli Lewis(Ben-Gurion University of the Negev), Pietro Ghezzi(Brighton and Sussex Medical School), Raphaela Goldbach‐Mansky(National Institutes of Health), Diana Boraschi(Institute of Biomedical Technologies), Theresa T. Pizarro(University School), Luke O'neill(Trinity College Dublin), Michael Kracht(Justus-Liebig-Universität Gießen), John E. Sims(Amgen (United States)), Daniela Novick(Weizmann Institute of Science), Frank L. van de Veerdonk(University Medical Center), Miodrag L. Lukić(University of Kragujevac), Bruno Conti(Scripps Research Institute), Anna Rubartelli(National Cancer Research Institute), Josef Pfeilschifter(Goethe University Frankfurt), Peyman Kelk(Umeå University), Jos van der Meer(Radboud University Nijmegen), Alan M. Solinger(XOMA (United States))
Cited by 341
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
|Cell Research|2015|1.8k
Macrophages as tools and targets in cancer therapy
|Nature Reviews Drug Discovery|2022|1.7k